Literature DB >> 11881124

Bioactive angiotensin peptides: focus on angiotensin IV.

T Mustafa1, J H Lee, S Y Chai, A L Albiston, S G McDowall, F A Mendelsohn.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11881124     DOI： 10.3317/jraas.2001.032

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN： 1470-3203            Impact factor:   1.636


× No keyword cloud information.
  13 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

2.  Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs.

Authors:  Caroline C Benoist; John W Wright; Mingyan Zhu; Suzanne M Appleyard; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2011-06-30       Impact factor: 4.030

Review 3.  Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics.

Authors:  Diana Klingler; Markus Hardt
Journal:  Circ Cardiovasc Genet       Date:  2012-04-01

Review 4.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

5.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

6.  Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.

Authors:  Alene T McCoy; Caroline C Benoist; John W Wright; Leen H Kawas; Jyote M Bule-Ghogare; Mingyan Zhu; Suzanne M Appleyard; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

7.  Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.

Authors:  Éva Larouche-Lebel; Kerry A Loughran; Mark A Oyama; Phil F Solter; Danielle S Laughlin; Melissa D Sánchez; Charles-Antoine Assenmacher; Philip R Fox; Ryan C Fries
Journal:  J Vet Intern Med       Date:  2019-06-28       Impact factor: 3.333

Review 8.  Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity.

Authors:  Dora L Vallejo-Ardila; Theodora Fifis; Louise M Burrell; Katrina Walsh; Christopher Christophi
Journal:  Oncotarget       Date:  2018-10-26

9.  Angiotensin II, III, and IV may be important in the progression of COVID-19.

Authors:  Erkan Cure; Tevfik Bulent Ilcol; Medine Cumhur Cure
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

Review 10.  A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Authors:  John W Wright; Leen H Kawas; Joseph W Harding
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-25       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.